Cancer Frontiers (Audio)

As part of the 2024 Prostate Cancer Patient Conference, Dr. Terence Friedlander discusses bone health in advanced prostate cancer. He reviews normal bone health and how it is affected by prostate cancer, defines important terms, and shares recommendations for optimizing bone health in prostate cancer.

Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39771]

As part of the 2024 Prostate Cancer Patient Conference, Dr. Hao Nguyen discusses focal therapy as a choice of therapy in patients with low and intermediate risk prostate cancer at high risk for progression.

Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39760]

As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small reviews Androgen Deprivation Therapy, including choices of agents, side effects, considerations in timing, duration, intensity of therapy, and discusses interpretation of clinical trial results.

Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39756]

As part of the 2024 Prostate Cancer Patient Conference, Dr. Mack Roach discusses the phenomenon of “biochemical recurrence” and approaches to risk assessment, following treatments for localized prostate cancer.

Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39761]

As part of the 2024 Prostate Cancer Patient Conference, Dr. Julian Hong discusses radiation therapy as treatment for prostate cancer, including potential side effects, considerations in decision making, the radiation oncology care path.

Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39759]

As part of the 2024 Prostate Cancer Patient Conference, Drs. June Chan and Stacey Kenfield present recommendations for diet and exercise based in research with prostate cancer patients. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39767]

As part of the 2024 Prostate Cancer Patient Conference, Dr. Ivan de Kouchkovksky discusses the use of both chemotherapy and radioligand therapy, including a “theranostic” approach, in metastatic treatment resistant prostate cancer.

Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39769]

As part of the 2024 Prostate Cancer Patient Conference, Dr. Jonathan Chou discusses individual genetics in the risk of developing prostate cancer, genomic testing to distinguish indolent verses more aggressive disease, and genomic testing to determine best treatment for individual patients. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39755]

This program demonstrates how to exercise when you don't have a great amount of time or energy. Natalie Marshall, MD, also discusses how to overcome barriers to daily exercise. Series: "Osher WISE: Well-being and Integrative Science for Everyone" [Health and Medicine] [Show ID: 38814]

As part of the 2024 Prostate Cancer Patient Conference, Dr. Kevin Shee presents a comprehensive overview of active surveillance in managing localized prostate cancer. Drawing from the extensive institutional database with over 9,000 participants at UCSF, Dr. Shee highlights groundbreaking insights into the field. From exploring the safety of active surveillance in younger men to investigating the potential of prostate MRI as a biopsy alternative, you'll gain valuable insights into treatment decisions and patient outcomes. Dr. Shee's session offers a profound understanding of how data-driven approaches are shaping the future of prostate cancer management. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39757]